Over ten percent of the U.S. population suffers disproportionate cardiometabolic risk because of their type 2 diabetes (T2DM). In light of recent data, GLP-1 receptor agonists (GLP-1 RAs) have taken on a more prominent role in T2DM management algorithms. This session will discuss how you can distinguish among GLP-1 RAs and use them in your practice to help manage the risks that these patients face beyond glucose control. A member of the Diabetes Sisters organization will also be joining us to discuss their experience with starting a GLP-1 RA as a patient.

What’s new in prostate cancer screening? Tune in to this webcast for the latest guidelines, screening methods, and data on the role of multi-parametric MRI of the prostate in screening and diagnosis of prostate cancer.

Cannabis use continues to rise in the United States, driven by expansion of laws legalizing recreational and medical use. With this increased use comes an increase in side effects, such as lung injuries from vaping and a rise in cannabis use disorder. We will discuss what practitioners should know about vaping and cannabis use, and what they should tell their patients. This session will also inform the attendees the most recent clinical and radiographic findings in patients diagnosed with e-cigarette and vaping associated acute lung injury.

As we see more patients with cognitive impairment, understanding the real-world care for this population is vital. This lecture will review the most efficient means of assessing cognitive impairment, examine common issues in caring for the older adult with cognitive impairment, and discuss pharmacologic/non-pharmacologic means of treating patients. Dr. Lindquist will also address updates on what medications are useless/useful and what testing should be avoided. Polypharmacy is common among older adults and associated with adverse outcomes. This case-based session will review how to avoid inappropriate prescribing, recognize adverse drug events, and identify opportunities to deprescribe. Dr. Bradley will review recent literature updates that inform our prescribing practices including the 2019 AGS Beers criteria. Tips to enhance safe medication use will be shared. The updates will be followed by an “Ask the Expert” session with Drs. Lindquist and Bradley where they will review common questions and take questions from attendees.

This talk will cover the potential and the challenges in genetic discovery that need to be met in order to support the utility of genomics in clinical care. Genome methods including whole genome sequencing will be covered. The successes in pediatric genetics will be contrasted with the greater challenges in adult medicine.

Asthma & chronic obstructive pulmonary disease (COPD) can have overlapping symptoms, but they are characterized by different pathogenic mechanisms and different responses to anti-inflammatory therapies. Dozens of medications and interventions have been approved and prescribed to combat these diseases, and treatments strategies have been developed that depend largely on severity of symptoms. But how should we approach these patients? What’s new in asthma and COPD? This case-based presentation will help you review what you need to know about asthma and COPD in 2020.

These troubling times require communication among specialists and primary care. In this COVID-19 ask the expert the faculty will discuss the most pressing and frequently asked questions about this disease and its complications.

While outpatient ethics training is relatively scant, many primary care clinicians encounter challenging situations in clinic that raise ethical considerations—and the pandemic has brought several important ethical questions and dilemmas to the forefront. This case-based discussion will review strategies for managing these moral dilemmas in the age of COVID-19.

The early detection of cancer can significantly improve the treatment and outcomes for patients. Screening is an effective tool for early detection, but emerging evidence constantly shift these recommendations. This case-based presentation will focus on the most recent guidelines from the leading agencies including ACS, NCCN, and USPSTF and discuss strategies on how to apply them to your patients.

In the twenty-second episode of Pri-Med’s web series on COVID-19, faculty will examine the concept of “herd immunity” and how it relates to the evolving COVID-19 pandemic. They will not only explain the basics of herd immunity but take a deep dive into why herd immunity may or may not help to limit the spread of COVID-19. This session will also re-visit the COVID-19 vaccine pipeline, explaining where we stand with current vaccine trials and the outlook for vaccine development.

COVID-19 has disproportionately impacted older adults through early high infection rates, social isolation, anxiety, depression and mortality. This session on polypharmacy and COVID-19 will improve how you treat the sequalae of COVID-19 in older adults and increase your awareness of polypharmacy. It will also provide the newest research on non-pharmacologic ways of treating the long-term effects of COVID-19 on older adults. Through interactive patient cases, Dr. Lee Lindquist will provide examples on how to safely and effectively manage the medications of your older adult patients during the COVID-19 pandemic. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 8/13/2020, and they are subject to change as new information is published.

Watch expert faculty discuss assess and treat migraine through the case of a young man with recurrent headaches. Treatment will focus on traditional and new preventive therapies for chronic migraine as well as patient self-management strategies to optimize management. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 8/13/2020, and they are subject to change as new information is published.